Evidence map›Paper›PMID 40219556›Full record

ArticleBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences2025

[Effect of intraoperative blood salvage autotransfusion on the prognosis of patients after carotid body tumor resection].

Weihao Li, Jing Li, Xuemin Zhang, Wei Li, Qingle Li, Xiaoming Zhang

Abstract readEnglish Abstract
PubMed Full text at PMC
In one paragraph

Article in Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Weihao LiDepartment of Vascular Surgery, Peking University People's Hospital, Beijing 100044, China.
Jing LiDepartment of Vascular Surgery, Peking University People's Hospital, Beijing 100044, China.
Xuemin ZhangDepartment of Vascular Surgery, Peking University People's Hospital, Beijing 100044, China.
Wei LiDepartment of Vascular Surgery, Peking University People's Hospital, Beijing 100044, China.
Qingle LiDepartment of Vascular Surgery, Peking University People's Hospital, Beijing 100044, China.
Xiaoming ZhangDepartment of Vascular Surgery, Peking University People's Hospital, Beijing 100044, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the effect of intraoperative blood salvage autotransfusion on local recurrence and long-term metastasis of patients after carotid body tumor resection.

methodsWe retrospectively reviewed a consecutive series of 61 patients undergoing elective carotid body tumor resection from August 2009 to December 2020. Among them, 14 received intraoperative blood salvage autotransfusion (autotrasfusion group) and 47 did not (non-autotransfusion). Data of general information, surgical status and postoperative follow-up results were collected.

resultsThe proportion of Shamblin Ⅲ in the autotransfusion group was 85.7%, which was significantly higher than 31.9% in the non-autotransfusion group (

conclusionThe use of intraoperative blood salvage autotransfusion increased no risk of local recurrence and distant metastasis in patients with carotid body tumor, which is safe and effective in carotid body tumor resection.

Indexed as

Blood Transfusion, AutologousCarotid Body TumorOperative Blood SalvageAdultAgedBlood Loss, SurgicalFemaleHumansMaleMiddle AgedNeoplasm Recurrence, LocalOperative TimePrognosisRetrospective StudiesBlood transfusion, autologousCarotid body tumorOperative blood salvagePrognosis

Identifiers

PMID40219556
PMCPMC11992442

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.